CN109821009B - 轴突导向因子重组蛋白Semaphorin3G的医药用途 - Google Patents
轴突导向因子重组蛋白Semaphorin3G的医药用途 Download PDFInfo
- Publication number
- CN109821009B CN109821009B CN201910057123.1A CN201910057123A CN109821009B CN 109821009 B CN109821009 B CN 109821009B CN 201910057123 A CN201910057123 A CN 201910057123A CN 109821009 B CN109821009 B CN 109821009B
- Authority
- CN
- China
- Prior art keywords
- sema3g
- recombinant protein
- cre
- cdh5
- cognitive dysfunction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910057123.1A CN109821009B (zh) | 2019-01-22 | 2019-01-22 | 轴突导向因子重组蛋白Semaphorin3G的医药用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910057123.1A CN109821009B (zh) | 2019-01-22 | 2019-01-22 | 轴突导向因子重组蛋白Semaphorin3G的医药用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109821009A CN109821009A (zh) | 2019-05-31 |
CN109821009B true CN109821009B (zh) | 2020-03-31 |
Family
ID=66861673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910057123.1A Active CN109821009B (zh) | 2019-01-22 | 2019-01-22 | 轴突导向因子重组蛋白Semaphorin3G的医药用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109821009B (zh) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2505440T3 (es) * | 2007-10-19 | 2014-10-09 | Rappaport Family Institute For Research In The Medical Sciences | Composiciones que comprenden semaforinas para el tratamiento de las enfermedades relacionadas con la angiogénesis y los procedimientos de selección de las mismas |
US9314501B2 (en) * | 2012-04-26 | 2016-04-19 | Riken | Method of regulating neuronal axon elongation |
BR112017017825A2 (pt) * | 2015-02-23 | 2018-04-10 | Seagull Therapeutics Sas | semaforinas 3 não naturais e seu uso médico |
CN108707660A (zh) * | 2018-06-29 | 2018-10-26 | 山西大学 | 大鼠基因在制备筛选药物的试剂中的应用 |
-
2019
- 2019-01-22 CN CN201910057123.1A patent/CN109821009B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN109821009A (zh) | 2019-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2301560A1 (en) | Pharmaceutical agent for promoting the functional regeneration of damaged tissue | |
JP2005536984A (ja) | オボムコイドプロモーターおよび使用方法 | |
CN110267980A (zh) | 诱导型胱天蛋白酶及使用方法 | |
US10711046B2 (en) | Method for establishing eukaryotic expression cell line of CD36 mutant gene that encodes CD36 deficiency | |
Pochampally et al. | Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects | |
Boda et al. | Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells | |
WO2012051599A2 (en) | Modulation neural pathways | |
CN114245803A (zh) | 用于重构小神经胶质细胞的方法和组合物 | |
CN111150854A (zh) | 一种改善自闭症社交障碍的方法 | |
Pekayvaz et al. | Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammation | |
CN109821009B (zh) | 轴突导向因子重组蛋白Semaphorin3G的医药用途 | |
US20060194201A1 (en) | Autism gene | |
CN112280800B (zh) | 一种构建体及其在制备动物衰老细胞示踪和衰老细胞清除药物中的应用 | |
US20230295654A1 (en) | Methods and compositions for treatment of fragile x syndrome | |
CN101161676A (zh) | 抑制hiv复制的突变型apobec3g分子及其应用 | |
Mich et al. | AAV-mediated interneuron-specific gene replacement for Dravet syndrome | |
CN101237884A (zh) | 与低氧应激反应有关的Int6蛋白及其用途 | |
US20100111913A1 (en) | Method of enhancing migration of neural precursor cells | |
CN113913433B (zh) | Jupiter基因在鳞翅目害虫防控中的应用 | |
US20230220402A1 (en) | Use of an orphan motif to increase expression of a heterologous transgene | |
WO2004042062A9 (en) | Porcine uroplakin ii promoter and the production method of useful proteins using said promoter | |
JP4262921B2 (ja) | リズムを有する発現をもたらすPeriod1プロモーターが導入されたトランスジェニック哺乳動物 | |
He | Identification of the genetic risks of craniosynostosis in zebrafish model | |
Pakalniškytė | Novel CD64-DTR mouse model generation using CRISPR-Cas9 technology and functional characterization of renal dendritic cells | |
CN117919451A (zh) | 与桥粒芯糖蛋白2相关的生物材料的应用及抑制骨再生病理性亢进的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Han Feng Inventor after: Jiang Quan Inventor after: Lu Nannan Inventor after: Tan Chao Inventor after: Lu Yingmei Inventor after: Sun Ninghe Inventor after: Chen Danyang Inventor after: Lin Wen Inventor after: Fei Ye Inventor after: Wang Chengkun Inventor before: Han Feng Inventor before: Lu Nannan Inventor before: Tan Chao Inventor before: Lu Yingmei Inventor before: Lin Wen Inventor before: Fei Ye Inventor before: Wang Chengkun Inventor before: Jiang Quan |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |